Search results: Sage Journals

Restricted accessResearch articleFirst published October, 1997

Pre-clinical pharmacology of zolmitriptan (Zomig™;formerly 311C90),a centrally and peripherally acting 5HT1B/1D agonist for migraine

Gr Martin

Cephalalgia

Restricted accessResearch articleFirst published October, 1997

Zolmitriptan (Zomig™,311C90),a novel dual central and peripheral 5HT1B/1D agonist: An overview of efficacy

J Schoenen, J Sawyer

Cephalalgia

Restricted accessResearch articleFirst published October, 1997

Tolerability profile of zolmitriptan (Zomig™ 311C90),a novel dual central and peripherally acting 5HT1B/1D agonist

Jg Edmeads, Ds Millson

Cephalalgia

Restricted accessResearch articleFirst published October, 1997

Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig™,311C90)

P Rolan

Cephalalgia

Free accessLetterFirst published May, 2007

Do 5HT1B/1D Receptor Agonists have an Effect on Mood and Anxiety Disorders?

Nicola Morelli, Sara Gori, Anna Choub [...]

Cephalalgia

Free accessResearch articleFirst published May, 2005

5-Hydroxytryptamine (5HT) Receptors in the Heart Valves of Cynomolgus Monkeys and Sprague-Dawley Rats

Chandikumar S. Elangbam, Ruth M. Lightfoot, Lawrence W. Yoon [...]

Journal of Histochemistry & Cytochemistry

Free accessResearch articleFirst published September, 1999

Open-Labeled Long-Term Study of the Efficacy,Safety,and Tolerability of Subcutaneous Sumatriptan in Acute Migraine Treatment

H Göbel, A Heinze, H Stolze [...]

Cephalalgia

Open accessReview articleFirst published 2009

Triptans in the Treatment of Migraine

Baburhan Guldiken

Clinical Medicine Insights: Therapeutics

Restricted accessCase reportFirst published April, 2019

DHE-Induced Peripheral Arterial Vasospasm in Primary Raynaud Phenomenon: Case Report

Jane Khalife, Clinton G. Lauritsen, John Liang [...]

The Neurohospitalist

Restricted accessResearch articleFirst published December, 1997

Intensity Dependence of the Cortical Auditory Evoked Potentials as A Surrogate Marker of Central Nervous System Serotonin Transmission in Man: Demonstration of A Central Effect for the 5Ht 1B/1D Agonist Zolmitriptan (311C90,Zomig®).

A Proietti-Cecchini, J Áfra, J Schoenen

Cephalalgia

Restricted accessResearch articleFirst published October, 1997

Pre-clinical pharmacology of zolmitriptan (Zomig™;formerly 311C90),a centrally and peripherally acting 5HT1B/1D agonist for migraine

Gr Martin

Cephalalgia

Restricted accessResearch articleFirst published October, 1997

Zolmitriptan (Zomig™,311C90),a novel dual central and peripheral 5HT1B/1D agonist: An overview of efficacy

J Schoenen, J Sawyer

Cephalalgia

Restricted accessResearch articleFirst published October, 1997

Tolerability profile of zolmitriptan (Zomig™ 311C90),a novel dual central and peripherally acting 5HT1B/1D agonist

Jg Edmeads, Ds Millson

Cephalalgia

Restricted accessResearch articleFirst published October, 1997

Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig™,311C90)

P Rolan

Cephalalgia

Free accessLetterFirst published May, 2007

Do 5HT1B/1D Receptor Agonists have an Effect on Mood and Anxiety Disorders?

Nicola Morelli, Sara Gori, Anna Choub [...]

Cephalalgia

Free accessResearch articleFirst published May, 2005

5-Hydroxytryptamine (5HT) Receptors in the Heart Valves of Cynomolgus Monkeys and Sprague-Dawley Rats

Chandikumar S. Elangbam, Ruth M. Lightfoot, Lawrence W. Yoon [...]

Journal of Histochemistry & Cytochemistry

Free accessResearch articleFirst published September, 1999

Open-Labeled Long-Term Study of the Efficacy,Safety,and Tolerability of Subcutaneous Sumatriptan in Acute Migraine Treatment

H Göbel, A Heinze, H Stolze [...]

Cephalalgia

Open accessReview articleFirst published 2009

Triptans in the Treatment of Migraine

Baburhan Guldiken

Clinical Medicine Insights: Therapeutics

Restricted accessCase reportFirst published April, 2019

DHE-Induced Peripheral Arterial Vasospasm in Primary Raynaud Phenomenon: Case Report

Jane Khalife, Clinton G. Lauritsen, John Liang [...]

The Neurohospitalist

Restricted accessResearch articleFirst published December, 1997

Intensity Dependence of the Cortical Auditory Evoked Potentials as A Surrogate Marker of Central Nervous System Serotonin Transmission in Man: Demonstration of A Central Effect for the 5Ht 1B/1D Agonist Zolmitriptan (311C90,Zomig®).

A Proietti-Cecchini, J Áfra, J Schoenen

Cephalalgia